Rituximab in Primary Lymphocyte Predominant Hodgkin´s Disease(RIPL)
Clinical trial NCT00346684 · COMPLETED
Trial details
- NCT number
- NCT00346684
- Sponsor
- University of Cologne
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-07-01
- Primary completion
- 2007-11-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.